Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Autor: Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ

Publikováno v: Journal of Clinical Oncology; 7/1/2008, Vol. 26 Issue 19, p3213-3221, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.

Autor: Azad N; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA., Hu Z; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sahin I; Department of Medicine University of Florida Health Cancer Center, Gainesville, FL 32610, USA., Iyer R; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA., Aranha O; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA., Hochster H; Gastrointestinal Oncology, Rutgers Cancer Institute New Jersey, New Brunswick, NJ 08903, USA., Pathak P; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Paulson AS; Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas, TX 75246, USA., Kalyan A; Robert H. Lurie Comprehensive Cancer, Division of Hematology & Oncology, Northwestern University, Chicago, IL 60611, USA., Liao CY; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA., Tran N; Department of Oncology, Division of Medical Oncology, Mayo Clinic Rochester, MN 55905, USA., Kelley RK; Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158, USA., Heestand G; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA., Cosgrove D; Sarah Cannon Research Institute, Compass Oncology, Vancouver, WA 98684, USA., El-Khoueiry A; USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA., Borad M; Department of Hematology-Oncology, Mayo Clinic Cancer Center, Phoenix, AZ 85054, USA., Gabrail NY; Gabrail Cancer Center Research, Canton, OH 44718, USA., Majeed U; Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA., Du L; Ochsner MD Anderson Cancer Center, Ochsner Health, New Orleans, LA 70115, USA., Kamath S; Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA., Shumway N; Texas Oncology, San Antonio, TX 78258, USA., Shroff R; Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA., Goyal L; Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, CA 94305, USA., Rosales M; Compass Therapeutics, 80 Guest Street, Boston, MA 02135, USA., Javle M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (30), pp. 2241-2248. Date of Electronic Publication: 2024 Jun 04.